The Integration of Sensor Technology Into Incontinence Materials: a Single-group Pretest-posttest Study in a Nursing Home Environment
NCT ID: NCT05316012
Last Updated: 2023-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2022-06-20
2022-11-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence
NCT04071301
inContAlert: Machine Learning Algorithms for Individual Bladder Filling Level Prediction
NCT05952700
Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
NCT05520346
Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor
NCT04362579
Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring
NCT04362553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Residents
5 residents - fase 1 Intervention device: smart diaper (diaper, sensor and strips, without alerting system).
15 residents -fase 2, of which 5 residents of study phase 1 Intervention device: smart diaper (diaper, sensor and strips, with alerting system)
Smart diapers
Residents receive standard continence care while using the smart diaper (without the alerting system) - fase 1
Diapers are changed as usual, e.g., after morning care, visual soiling, unpleasant odor, saturation, leakage.
Residents receive continence care while using the smart diaper with the alerting system - fase 2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smart diapers
Residents receive standard continence care while using the smart diaper (without the alerting system) - fase 1
Diapers are changed as usual, e.g., after morning care, visual soiling, unpleasant odor, saturation, leakage.
Residents receive continence care while using the smart diaper with the alerting system - fase 2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Urinary incontinence or double incontinence (Katz score incontinence ≥ 3) by day and night. (Score assessed in one week interval before start study period 1 and 2 "D1")
* Wearing adult diapers as incontinence material, size M.
* Unable to change diaper independently when saturated or leaking (Katz score toileting ≥ 3). (Score assessed in one week interval before start study period 1 and 2 "D1")
* Written informed consent from resident or resident's legal representative.
* Dutch speaking
Exclusion Criteria
* Residents with a Mini-Mental State Examination (MMSE)-score of \< 24
* Residents with a dominant belly sleeping position
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WZC Heilig Hart vzw
Oudenaarde, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BC-09902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.